IM Cannabis Statistics
Total Valuation
IM Cannabis has a market cap or net worth of $895,536. The enterprise value is $10.89 million.
| Market Cap | 895,536 |
| Enterprise Value | 10.89M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IM Cannabis has 6.22 million shares outstanding. The number of shares has increased by 93.35% in one year.
| Current Share Class | 6.22M |
| Shares Outstanding | 6.22M |
| Shares Change (YoY) | +93.35% |
| Shares Change (QoQ) | +3.45% |
| Owned by Insiders (%) | 23.36% |
| Owned by Institutions (%) | 0.46% |
| Float | 4.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.64 |
| P/OCF Ratio | 18.66 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 311.86 |
Financial Position
The company has a current ratio of 0.55
| Current Ratio | 0.55 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 306.81 |
| Interest Coverage | -1.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -14.63% |
| Return on Invested Capital (ROIC) | -68.76% |
| Return on Capital Employed (ROCE) | 199.83% |
| Weighted Average Cost of Capital (WACC) | 22.26% |
| Revenue Per Employee | $828,912 |
| Profits Per Employee | -$225,846 |
| Employee Count | 44 |
| Asset Turnover | 1.48 |
| Inventory Turnover | 11.64 |
Taxes
In the past 12 months, IM Cannabis has paid $57,312 in taxes.
| Income Tax | 57,312 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.56% in the last 52 weeks. The beta is 2.04, so IM Cannabis's price volatility has been higher than the market average.
| Beta (5Y) | 2.04 |
| 52-Week Price Change | -95.56% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.93 |
| Relative Strength Index (RSI) | 35.60 |
| Average Volume (20 Days) | 2,003,362 |
Short Selling Information
The latest short interest is 373,494, so 6.00% of the outstanding shares have been sold short.
| Short Interest | 373,494 |
| Short Previous Month | 143,367 |
| Short % of Shares Out | 6.00% |
| Short % of Float | 9.19% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, IM Cannabis had revenue of $36.47 million and -$9.94 million in losses. Loss per share was -$2.01.
| Revenue | 36.47M |
| Gross Profit | 5.49M |
| Operating Income | -5.75M |
| Pretax Income | -10.25M |
| Net Income | -9.94M |
| EBITDA | -4.56M |
| EBIT | -5.75M |
| Loss Per Share | -$2.01 |
Balance Sheet
The company has $719,270 in cash and $10.72 million in debt, with a net cash position of -$10.00 million or -$1.61 per share.
| Cash & Cash Equivalents | 719,270 |
| Total Debt | 10.72M |
| Net Cash | -10.00M |
| Net Cash Per Share | -$1.61 |
| Equity (Book Value) | -3.67M |
| Book Value Per Share | -0.58 |
| Working Capital | -9.03M |
Cash Flow
In the last 12 months, operating cash flow was $47,999 and capital expenditures -$12,895, giving a free cash flow of $34,931.
| Operating Cash Flow | 47,999 |
| Capital Expenditures | -12,895 |
| Depreciation & Amortization | 1.19M |
| Net Borrowing | -129,032 |
| Free Cash Flow | 34,931 |
| FCF Per Share | $0.01 |
Margins
Gross margin is 15.04%, with operating and profit margins of -15.77% and -27.25%.
| Gross Margin | 15.04% |
| Operating Margin | -15.77% |
| Pretax Margin | -28.11% |
| Profit Margin | -27.25% |
| EBITDA Margin | -12.50% |
| EBIT Margin | -15.77% |
| FCF Margin | 0.10% |
Dividends & Yields
IM Cannabis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -93.35% |
| Shareholder Yield | -93.35% |
| Earnings Yield | -1,109.64% |
| FCF Yield | 3.90% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 23.68% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2024. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
IM Cannabis has an Altman Z-Score of -15.46 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.46 |
| Piotroski F-Score | 3 |